Northwest Biotherapeutics | NWBO - 销售和管理费用





销售和管理费用 更改 日
Agenus USD 6.21M 4.34M 2026-03
AstraZeneca USD 5.8B 735M 2026-06
Bristol-Myers Squibb USD 1.83B 209M 2026-06
Celldex Therapeutics USD 13.1M 1.65M 2026-06
Eisai JPY 114.83B 4.71B 2026-06
Merck USD 2.89B 219M 2026-06
Northwest Biotherapeutics USD 6.54M 534K 2026-03
Pfizer USD 3.41B 496M 2026-06
Plus Therapeutics USD 4.26M 779K 2026-03
Roche Holding CHF 6.37B 908M 2026-06